Literature DB >> 8683725

Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats.

Y H Lee1, W C Huang, J K Huang, L S Chang.   

Abstract

PURPOSE: The present study was conducted to extend our earlier study on the role of testosterone in the pathogenesis of urolithiasis and to further investigate the influence of sex hormone on the pathogenesis of calcium oxalate stone.
MATERIALS AND METHODS: Adult Sprague-Dawley rats were divided into 9 groups, each containing 10 rats. Two groups of rats were left untreated and served as male and female controls. Another 7 groups of rats were fed a 0.5% ethylene glycol (EG) lithogenic diet for 4 weeks. Among them, 2 groups were male and female rats, 2 groups were castrated, 2 groups were castrated and then were subcutaneously implanted with testosterone, and 1 group of intact female rats was also subcutaneously implanted with testosterone. The stone and crystal deposits were examined by infrared spectrometer and polarizing and scanning electron microscope, respectively. Serum testosterone, creatinine and electrolytes and the renal excretion of, oxalate, citrate and creatinine were determined.
RESULTS: Subcutaneous implantation of exogenous testosterone restored calcium oxalate stone formation in castrated, EG-treated male rats (80%) and enhanced urolithiasis in castrated female rats receiving EG (40%). However, the testosterone effect was less striking in intact female rats fed EG (10%).
CONCLUSIONS: These data suggest that testosterone can promote and estrogen may inhibit calcium oxalate stone formation in EG-treated rats.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683725     DOI: 10.1097/00005392-199608000-00071

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Antioxidants inhibition of high plasma androgenic markers in the pathogenesis of ethylene glycol (EG)-induced nephrolithiasis in Wistar rats.

Authors:  Mohammad Reza Naghii; Mahmood Mofid; Mehdi Hedayati; Kazem Khalagi
Journal:  Urolithiasis       Date:  2013-11-08       Impact factor: 3.436

2.  Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels.

Authors:  Emre Can Polat; Levent Ozcan; Alper Otunctemur; Emin Ozbek
Journal:  Urolithiasis       Date:  2016-05-07       Impact factor: 3.436

3.  Sex Steroid Hormone Levels May Not Explain Gender Differences in Development of Nephrolithiasis.

Authors:  John Joseph Knoedler; Amy E Krambeck; Walter Astorne; Erik Bergstralh; John Lieske
Journal:  J Endourol       Date:  2015-11-05       Impact factor: 2.942

4.  Testosterone replacement therapy is associated with an increased risk of urolithiasis.

Authors:  Tyler R McClintock; Marie-Therese I Valovska; Nicollette K Kwon; Alexander P Cole; Wei Jiang; Martin N Kathrins; Naeem Bhojani; George E Haleblian; Tracey Koehlmoos; Adil H Haider; Shehzad Basaria; Quoc-Dien Trinh
Journal:  World J Urol       Date:  2019-03-23       Impact factor: 4.226

5.  An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.

Authors:  Nasser Shakhssalim; Kobra Roohi Gilani; Mahmoud Parvin; Peyman Mohammadi Torbati; Amir H Kashi; Mohaddeseh Azadvari; Banafsheh Golestan; Abbas Basiri
Journal:  Urol Res       Date:  2010-05-19

6.  Influence of estrus status on urinary chemical parameters related to urolithiasis.

Authors:  Yuji Kato; Satoshi Yamaguchi; Hidehiro Kakizaki; Sunao Yachiku
Journal:  Urol Res       Date:  2005-11-26

7.  Is polycystic ovarian syndrome a risk factor for urolithiasis?

Authors:  Ikbal Kaygusuz; Omer Faruk Karatas; Hasan Kafali; Ersin Cimentepe; Dogan Unal
Journal:  Urolithiasis       Date:  2013-04-21       Impact factor: 3.436

8.  Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis.

Authors:  Rama Devi Mittal; D K Mishra; P Srivastava; P Manchanda; H K Bid; R Kapoor
Journal:  Indian J Clin Biochem       Date:  2010-05-27

9.  The liver and kidney expression of sulfate anion transporter sat-1 in rats exhibits male-dominant gender differences.

Authors:  Hrvoje Brzica; Davorka Breljak; Wolfgang Krick; Mila Lovrić; Gerhard Burckhardt; Birgitta C Burckhardt; Ivan Sabolić
Journal:  Pflugers Arch       Date:  2008-11-11       Impact factor: 3.657

10.  In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria.

Authors:  Davorka Breljak; Hrvoje Brzica; Ivana Vrhovac; Vedran Micek; Dean Karaica; Marija Ljubojević; Ankica Sekovanić; Jasna Jurasović; Dubravka Rašić; Maja Peraica; Mila Lovrić; Nina Schnedler; Maja Henjakovic; Waja Wegner; Gerhard Burckhardt; Birgitta C Burckhardt; Ivan Sabolić
Journal:  Croat Med J       Date:  2015-10       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.